FWM
BIIB icon

Focused Wealth Management’s Biogen BIIB Stock Holding History

Focused Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,400
Closed -$8K – 949
2022
Q2 		$8K Buy
+2,400
New +$491K ﹤0.01% 526
2018
Q4 		– Sell
-2,000
Closed -$33K – 686
2018
Q3 		$33K Buy
+2,000
New +$689K 0.01% 326

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Focused Wealth Management's BIIB Position: Q1 2024 in Review

Focused Wealth Management sold out of Biogen (BIIB) in Q1 2024, closing a stake of 100 shares — an estimated $25.9K sold.

Focused Wealth Management first reported a position in BIIB in Q3 2013 and held it in 42 quarters. The position peaked at $266K in Q3 2017. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Focused Wealth Management reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 100 Biogen shares in Q1 2024, an estimated $25.9K.
  • Focused Wealth Management first reported a position in Biogen in Q3 2013 and held it in 42 quarters.
  • Focused Wealth Management's Biogen position peaked at $266K in Q3 2017.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.